GRF Antibodies

Santa Cruz Biotechnology provides a broad selection of GRF Antibodies for research focused on understanding growth hormone regulation. GRF Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Growth hormone-releasing factor (GRF) plays a crucial role in stimulating the secretion of growth hormone from the pituitary gland, influencing growth and metabolism. Understanding GRF function is essential for elucidating its impact on developmental processes and potential implications in growth disorders. The study of GRF can provide insights into various endocrine functions and their dysregulation in diseases. GRF research advances our knowledge of hormone signaling pathways and their regulation in normal physiological conditions. Investigating GRF mechanisms helps identify potential therapeutic targets for treating growth-related disorders. Research using GRF monoclonal antibodies contributes significantly to advancing endocrine system understanding and developing targeted treatments for hormone-related conditions.